Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Pharmaceutical Anti-Counterfeiting Technologies Market by Product (Barcodes, Radiofrequency Identification (RFID), Holograms/OVD, Taggants, Others) and by Technology Type (Authentication Technology, Track and Trace Technology): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03848

Pages: NA

Charts: NA

Tables: NA

Counterfeit medicines are manufactured by contaminating or using the wrong compounds with no active ingredient. These are drugs are illegal and pose a significant health risks. Thus, anti-counterfeiting technologies play a pivotal role in the identification of fake medicines. These technologies are highly adopted in the pharmaceutical industries to avoid substantial public health hazards. The factors that fuel the growth of the global pharmaceutical anti-counterfeiting technologies market are rise in availability of counterfeited pharmaceuticals and increase in government initiatives to spread awareness regarding fake medicines. However, lack of awareness towards anti-counterfeiting technologies in the developing economies is anticipated to restrain the market growth. Conversely, technological advancements in pharmaceutical anti-counterfeiting technologies are anticipated to offer lucrative opportunities for the expansion of the market.

The market is segmented on the basis of product, technology, and region. Based on product, the market is categorized into barcodes, radiofrequency identification (RFID), holograms/OVD, taggants, and others. By technology, it is classified into authentication technology and track & trace technology. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in the market are 3M Company, Alien Technology, Alpvision, Angstrom Technologies, ThermoFisher Scientific, Authentix, Inc., Avery Dennison Corporation, Colorcon, Covectra, and Everest Holovisions Ltd.

Key Benefits

  • The study provides an in-depth analysis of the global pharmaceutical anti-counterfeiting technologies market with current trends and future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis to enable stakeholders to capitalize on prevailing market opportunities.
  • Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.
  • Extensive analysis of the market by product assists to understand various forms of anti-counterfeiting technologies available.

 Key Market Segments

  • By Product
    • Barcodes
    • Radiofrequency Identification (RFID)
    • Holograms/OVD
    • Taggants
    • Others
  • By Technology Type
    • Authentication Technology
    • Track and Trace Technology
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Everest Holovisions Ltd.
  • Authentix, Inc.
  • Alpvision
  • Colorcon
  • Angstrom Technologies
  • 3M Company
  • ThermoFisher Scientific
  • Avery Dennison Corporation
  • Alien Technology
  • Covectra

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Barcodes

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Radiofrequency Identification (RFID)

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Holograms/OVD

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Taggants

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET, BY TECHNOLOGY TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Technology Type

    • 5.2. Authentication Technology

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Track And Trace Technology

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By Technology Type

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By Technology Type

      • 6.2.6. Canada Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By Technology Type

      • 6.2.7. Mexico Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By Technology Type

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By Technology Type

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By Technology Type

      • 6.3.6. Germany Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By Technology Type

      • 6.3.7. Italy Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By Technology Type

      • 6.3.8. Spain Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By Technology Type

      • 6.3.9. UK Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By Technology Type

      • 6.3.10. Russia Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By Technology Type

      • 6.3.11. Rest Of Europe Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By Technology Type

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By Technology Type

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By Technology Type

      • 6.4.6. Japan Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By Technology Type

      • 6.4.7. India Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By Technology Type

      • 6.4.8. South Korea Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By Technology Type

      • 6.4.9. Australia Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By Technology Type

      • 6.4.10. Thailand Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By Technology Type

      • 6.4.11. Malaysia Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By Technology Type

      • 6.4.12. Indonesia Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By Technology Type

      • 6.4.13. Rest of Asia Pacific Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By Technology Type

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By Technology Type

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By Technology Type

      • 6.5.6. South Africa Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By Technology Type

      • 6.5.7. Saudi Arabia Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By Technology Type

      • 6.5.8. UAE Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By Technology Type

      • 6.5.9. Argentina Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By Technology Type

      • 6.5.10. Rest of LAMEA Pharmaceutical Anti-counterfeiting Technologies Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By Technology Type

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. 3M Company

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Alien Technology

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Alpvision

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Angstrom Technologies

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. ThermoFisher Scientific

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Authentix, Inc.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Avery Dennison Corporation

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Colorcon

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Covectra

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Everest Holovisions Ltd.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR BARCODES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR RADIOFREQUENCY IDENTIFICATION (RFID), BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR HOLOGRAMS/OVD, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR TAGGANTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR AUTHENTICATION TECHNOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR TRACK AND TRACE TECHNOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 14. U.S. PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 15. U.S. PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 16. CANADA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 17. CANADA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. MEXICO PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 24. FRANCE PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 26. GERMANY PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 27. ITALY PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. ITALY PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 30. SPAIN PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. UK PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. UK PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 34. RUSSIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 36. REST OF EUROPE PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. CHINA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. CHINA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 43. JAPAN PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 44. INDIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 45. INDIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 47. SOUTH KOREA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 49. AUSTRALIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 51. THAILAND PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 53. MALAYSIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 55. INDONESIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 62. BRAZIL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH AFRICA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. SAUDI ARABIA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 67. UAE PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 68. UAE PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 70. ARGENTINA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 72. REST OF LAMEA PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES, BY TECHNOLOGY TYPE, 2025-2033 ($MILLION)
  • TABLE 73. 3M COMPANY: KEY EXECUTIVES
  • TABLE 74. 3M COMPANY: COMPANY SNAPSHOT
  • TABLE 75. 3M COMPANY: OPERATING SEGMENTS
  • TABLE 76. 3M COMPANY: PRODUCT PORTFOLIO
  • TABLE 77. 3M COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. ALIEN TECHNOLOGY: KEY EXECUTIVES
  • TABLE 79. ALIEN TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 80. ALIEN TECHNOLOGY: OPERATING SEGMENTS
  • TABLE 81. ALIEN TECHNOLOGY: PRODUCT PORTFOLIO
  • TABLE 82. ALIEN TECHNOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. ALPVISION: KEY EXECUTIVES
  • TABLE 84. ALPVISION: COMPANY SNAPSHOT
  • TABLE 85. ALPVISION: OPERATING SEGMENTS
  • TABLE 86. ALPVISION: PRODUCT PORTFOLIO
  • TABLE 87. ALPVISION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. ANGSTROM TECHNOLOGIES: KEY EXECUTIVES
  • TABLE 89. ANGSTROM TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 90. ANGSTROM TECHNOLOGIES: OPERATING SEGMENTS
  • TABLE 91. ANGSTROM TECHNOLOGIES: PRODUCT PORTFOLIO
  • TABLE 92. ANGSTROM TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. THERMOFISHER SCIENTIFIC: KEY EXECUTIVES
  • TABLE 94. THERMOFISHER SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 95. THERMOFISHER SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 96. THERMOFISHER SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 97. THERMOFISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. AUTHENTIX, INC.: KEY EXECUTIVES
  • TABLE 99. AUTHENTIX, INC.: COMPANY SNAPSHOT
  • TABLE 100. AUTHENTIX, INC.: OPERATING SEGMENTS
  • TABLE 101. AUTHENTIX, INC.: PRODUCT PORTFOLIO
  • TABLE 102. AUTHENTIX, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. AVERY DENNISON CORPORATION: KEY EXECUTIVES
  • TABLE 104. AVERY DENNISON CORPORATION: COMPANY SNAPSHOT
  • TABLE 105. AVERY DENNISON CORPORATION: OPERATING SEGMENTS
  • TABLE 106. AVERY DENNISON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 107. AVERY DENNISON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. COLORCON: KEY EXECUTIVES
  • TABLE 109. COLORCON: COMPANY SNAPSHOT
  • TABLE 110. COLORCON: OPERATING SEGMENTS
  • TABLE 111. COLORCON: PRODUCT PORTFOLIO
  • TABLE 112. COLORCON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. COVECTRA: KEY EXECUTIVES
  • TABLE 114. COVECTRA: COMPANY SNAPSHOT
  • TABLE 115. COVECTRA: OPERATING SEGMENTS
  • TABLE 116. COVECTRA: PRODUCT PORTFOLIO
  • TABLE 117. COVECTRA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. EVEREST HOLOVISIONS LTD.: KEY EXECUTIVES
  • TABLE 119. EVEREST HOLOVISIONS LTD.: COMPANY SNAPSHOT
  • TABLE 120. EVEREST HOLOVISIONS LTD.: OPERATING SEGMENTS
  • TABLE 121. EVEREST HOLOVISIONS LTD.: PRODUCT PORTFOLIO
  • TABLE 122. EVEREST HOLOVISIONS LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET
  • FIGURE 3. SEGMENTATION PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET
  • FIGURE 11. PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR BARCODES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR RADIOFREQUENCY IDENTIFICATION (RFID), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR HOLOGRAMS/OVD, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR TAGGANTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET SEGMENTATION, BY BY TECHNOLOGY TYPE
  • FIGURE 18. PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR AUTHENTICATION TECHNOLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET FOR TRACK AND TRACE TECHNOLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET
  • FIGURE 26. TOP PLAYER POSITIONING, 2024
  • FIGURE 27. 3M COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. 3M COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. 3M COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. ALIEN TECHNOLOGY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. ALIEN TECHNOLOGY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. ALIEN TECHNOLOGY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. ALPVISION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. ALPVISION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. ALPVISION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. ANGSTROM TECHNOLOGIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. ANGSTROM TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. ANGSTROM TECHNOLOGIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. THERMOFISHER SCIENTIFIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. THERMOFISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. THERMOFISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. AUTHENTIX, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. AUTHENTIX, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. AUTHENTIX, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. AVERY DENNISON CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. AVERY DENNISON CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. AVERY DENNISON CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. COLORCON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. COLORCON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. COLORCON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. COVECTRA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. COVECTRA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. COVECTRA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. EVEREST HOLOVISIONS LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. EVEREST HOLOVISIONS LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. EVEREST HOLOVISIONS LTD.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Pharmaceutical Anti-Counterfeiting Technologies Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved